{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:42:43Z","timestamp":1790188963118,"version":"4.1.0"},"reference-count":195,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":1877,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["15\u2010007374"],"award-info":[{"award-number":["15\u2010007374"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1111\/ajt.14382","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T02:26:40Z","timestamp":1496024800000},"page":"2509-2530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":185,"title":["Skin Cancers in Organ Transplant Recipients"],"prefix":"10.1016","volume":"17","author":[{"given":"A.","family":"Mittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.R.","family":"Colegio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14382_bib1","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14382_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0041-1345(96)00153-4","article-title":"Malignancy after renal transplantation: Analysis of incidence and risk factors in 1700 patients followed during a 25-year period","volume":"29","author":"Hiesse","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.14382_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.det.2011.02.004","article-title":"Management of skin cancer in solid-organ transplant recipients: A multidisciplinary approach","volume":"29","author":"Greenberg","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1111\/ajt.14382_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002018-200023020-00002","article-title":"Post-transplant malignancy: The role of immunosuppression","volume":"23","author":"Penn","year":"2000","journal-title":"Drug Saf"},{"key":"10.1111\/ajt.14382_bib5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/00005537-200008000-00006","article-title":"Head and neck cancer in cardiothoracic transplant recipients","volume":"110","author":"Pollard","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1111\/ajt.14382_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ajt.13978","article-title":"Cancer screening recommendations for solid organ transplant recipients: A systematic review of clinical practice guidelines","volume":"17","author":"Acuna","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.07021.x","article-title":"A population-based study of skin cancer incidence and prevalence in renal transplant recipients","volume":"154","author":"Moloney","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/bjd.14153","article-title":"Risk of basal cell carcinoma in Swedish organ transplant recipients: A population-based study","volume":"174","author":"Krynitz","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3390\/jcm4061229","article-title":"Cutaneous squamous cell carcinomas in organ transplant recipients","volume":"4","author":"Chockalingam","year":"2015","journal-title":"J Clin Med"},{"issue":"4 Pt 2","key":"10.1111\/ajt.14382_bib10","first-page":"651","article-title":"In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: Clinical characteristics, management, and outcome in a series of 21 patients","volume":"30","author":"Carucci","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/ajt.14382_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/ejso.2001.1119","article-title":"Incidence and clinical course of de-novo malignancies in renal allograft recipients","volume":"27","author":"Winkelhorst","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"10.1111\/ajt.14382_bib12","first-page":"182","article-title":"The immune system and skin cancer","volume":"810","author":"Yu","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/ajt.14382_bib13","first-page":"515","article-title":"Mechanisms involved in ultraviolet light-induced immunosuppression","volume":"13","author":"Aubin","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1111\/ajt.14382_bib14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/jid.2013.46","article-title":"Cutaneous human papillomavirus infection and Basal cell carcinoma of the skin","volume":"133","author":"Ally","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ajt.14382_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1155\/2007\/942650","article-title":"Human papillomaviruses and non-melanoma skin cancer: Basic virology and clinical manifestations","volume":"23","author":"Nindl","year":"2007","journal-title":"Dis Markers"},{"key":"10.1111\/ajt.14382_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ctrv.2013.08.005","article-title":"Papillomavirus-associated squamous skin cancers following transplant immunosuppression: One Notch closer to control","volume":"40","author":"Connolly","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1111\/ajt.14382_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/1055-9965.EPI-12-0917-T","article-title":"Human papillomavirus load in eyebrow hair follicles and risk of cutaneous squamous cell carcinoma","volume":"22","author":"Neale","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/ajt.14382_bib18","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/bjc.2011.95","article-title":"High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients","volume":"104","author":"Reuschenbach","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1111\/ajt.14382_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.abb.2011.01.004","article-title":"Pathogenesis of nonmelanoma skin cancers in organ transplant recipients","volume":"508","author":"Athar","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/ajt.14382_bib20","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/jid.2011.91","article-title":"Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma","volume":"131","author":"Arron","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ajt.14382_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature08996","article-title":"Opposing roles for calcineurin and ATF3 in squamous skin cancer","volume":"465","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"10.1111\/ajt.14382_bib22","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: Reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mito.2009.10.001","article-title":"Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients","volume":"10","author":"Norman","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1111\/ajt.14382_bib24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","article-title":"Cyclosporine induces cancer progression by a cell-autonomous mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"key":"10.1111\/ajt.14382_bib25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mc.20744","article-title":"Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: Role of TGFbeta signaling pathway","volume":"50","author":"Walsh","year":"2011","journal-title":"Mol Carcinog"},{"key":"10.1111\/ajt.14382_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00007890-198709000-00021","article-title":"Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice","volume":"44","author":"Kelly","year":"1987","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib27","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/nar\/gkp070","article-title":"Reactive oxygen species generated by thiopurine\/UVA cause irreparable transcription-blocking DNA lesions","volume":"37","author":"Brem","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1111\/ajt.14382_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.dnarep.2006.11.003","article-title":"Novel DNA lesions generated by the interaction between therapeutic thiopurines and UVA light","volume":"6","author":"Zhang","year":"2007","journal-title":"DNA Repair (Amst)"},{"key":"10.1111\/ajt.14382_bib29","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1751-1097.2010.00771.x","article-title":"Photo-oxidation of 6-thioguanine by UVA: The formation of addition products with low molecular weight thiol compounds","volume":"86","author":"Ren","year":"2010","journal-title":"Photochem Photobiol"},{"key":"10.1111\/ajt.14382_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00841366","article-title":"[Is fluidization of the phospholipid bilayer by general anesthetics a reason for general anesthesia?","volume":"112","author":"Burt","year":"1991","journal-title":"Biull Eksp Biol Med"},{"key":"10.1111\/ajt.14382_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2133.2011.10507.x","article-title":"Roles of the immune system in skin cancer","volume":"165","author":"Rangwala","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib32","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1681\/ASN.2009111109","article-title":"Five-year safety and efficacy of belatacept in renal transplantation","volume":"21","author":"Vincenti","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.14382_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1067\/S0190-9622(03)00902-2","article-title":"Factors associated with nonmelanoma skin cancer following renal transplantation in Queensland, Australia","volume":"49","author":"Ramsay","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib34","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.jid.5700776","article-title":"Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: A case-control study in The Netherlands, United Kingdom, Germany, France, and Italy","volume":"127","author":"Bouwes Bavinck","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"2 Pt 1","key":"10.1111\/ajt.14382_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"40","author":"Jensen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib36","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/jid.2009.181","article-title":"Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients","volume":"129","author":"Wisgerhof","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ajt.14382_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2014.09.010","article-title":"Incidence and risk factors for skin cancer following lung transplantation","volume":"72","author":"Rashtak","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/TP.0b013e3181d84cdc","article-title":"Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: Cumulative incidence and risk factors","volume":"89","author":"Wisgerhof","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib39","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archdermatol.2009.276","article-title":"Incidence of and risk factors for skin cancer after heart transplant","volume":"145","author":"Brewer","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/ajt.14382_bib40","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2133.2002.04976.x","article-title":"Non-melanoma skin cancer risk in the Queensland renal transplant population","volume":"147","author":"Ramsay","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/00007890-199603150-00008","article-title":"The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study","volume":"61","author":"Bouwes Bavinck","year":"1996","journal-title":"Transplantation"},{"issue":"4 Pt 2","key":"10.1111\/ajt.14382_bib42","first-page":"622","article-title":"Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients","volume":"30","author":"Ulrich","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/ajt.14382_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1053-2498(99)00137-0","article-title":"Skin cancer in heart transplant recipients: Frequency and risk factor analysis","volume":"19","author":"Fortina","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/ajt.14382_bib44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaad.2005.07.061","article-title":"Skin cancer in organ transplant recipients: Effect of pretransplant end-organ disease","volume":"53","author":"Otley","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib45","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/j.1600-6143.2008.02386.x","article-title":"Skin cancer in organ transplant recipients\u2013where do we stand today?","volume":"8","author":"Ulrich","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.tp.0000269707.06060.dc","article-title":"Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients","volume":"84","author":"Ramsay","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib47","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.TP.0000108491.62935.DF","article-title":"Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate","volume":"77","author":"Bordea","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib48","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1046\/j.1523-1747.2000.0202a-3.x","article-title":"A prospective study of incident nonmelanoma skin cancer in heart transplant recipients","volume":"115","author":"Espana","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ajt.14382_bib49","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0041-1345(96)00152-2","article-title":"Skin tumours posttransplantation: A retrospective analysis of 28 years\u2019 experience at a single centre","volume":"29","author":"Webb","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.14382_bib50","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in The Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib51","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/bjs.1800761005","article-title":"Skin cancer in renal transplant recipients","volume":"76","author":"Liddington","year":"1989","journal-title":"Br J Surg"},{"key":"10.1111\/ajt.14382_bib52","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(97)80015-3","article-title":"Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients","volume":"349","author":"Glover","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/ajt.14382_bib53","first-page":"44","article-title":"Skin cancer after renal transplantation: Results of a multicenter study in Iran","volume":"15","author":"Einollahi","year":"2010","journal-title":"Ann Transplant"},{"key":"10.1111\/ajt.14382_bib54","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.transproceed.2010.08.003","article-title":"Incidence and risk factors for nonmelanoma skin cancer after heart transplantation","volume":"42","author":"Molina","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.14382_bib55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14382_bib56","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib57","doi-asserted-by":"crossref","first-page":"g6679","DOI":"10.1136\/bmj.g6679","article-title":"Effect of sirolimus on malignancy and survival after kidney transplantation: Systematic review and meta-analysis of individual patient data","volume":"349","author":"Knoll","year":"2014","journal-title":"BMJ"},{"key":"10.1111\/ajt.14382_bib58","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2015.5548","article-title":"Association of sirolimus use with risk for skin cancer in a mixed-organ cohort of solid-organ transplant recipients with a history of cancer","volume":"152","author":"Karia","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1111\/ajt.14382_bib59","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.seminoncol.2016.02.019","article-title":"Cutaneous squamous cell carcinomas in solid organ transplant recipients: Emerging strategies for surveillance, staging, and treatment","volume":"43","author":"Kim","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1111\/ajt.14382_bib60","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/ajt.13431","article-title":"Voriconazole exposure and risk of cutaneous squamous cell carcinoma, aspergillus colonization, invasive aspergillosis and death in lung transplant recipients","volume":"16","author":"Mansh","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib61","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/cid\/cit940","article-title":"Voriconazole-associated cutaneous malignancy: A literature review on photocarcinogenesis in organ transplant recipients","volume":"58","author":"Williams","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ajt.14382_bib62","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11864-012-0195-3","article-title":"Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients","volume":"13","author":"Bangash","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"10.1111\/ajt.14382_bib63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/ajkd.2000.8290","article-title":"Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients","volume":"36","author":"Ramsay","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.14382_bib64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jaad.2016.09.003","article-title":"The natural history of actinic keratoses in organ transplant recipients","volume":"76","author":"Jiyad","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib65","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/ajd.12158","article-title":"The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses","volume":"55","author":"Ingham","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1111\/ajt.14382_bib66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/039463201002300201","article-title":"Efforts to counteract locally the effects of systemic immunosupression: A review on the use of imiquimod, a topical immunostimulator in organ transplant recipients","volume":"23","author":"Trakatelli","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"Suppl 2","key":"10.1111\/ajt.14382_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.08269.x","article-title":"Topical immunomodulation under systemic immunosuppression: Results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients","volume":"157","author":"Ulrich","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2133.2006.07233.x","article-title":"Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: A report of six cases","volume":"155","author":"Ulrich","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000323737","article-title":"Acute renal failure caused by imiquimod 5% cream in a renal transplant patient: Review of the literature on side effects of imiquimod","volume":"222","author":"Santos-Juanes","year":"2011","journal-title":"Dermatology"},{"key":"10.1111\/ajt.14382_bib70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.TP.0000107284.04969.5C","article-title":"Topical photodynamic therapy in the treatment of actinic keratoses and Bowen\u2019s disease in transplant recipients","volume":"77","author":"Dragieva","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib71","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.transproceed.2007.05.040","article-title":"Topical photodynamic therapy of actinic keratosis in renal transplant recipients","volume":"39","author":"Piaserico","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.14382_bib72","doi-asserted-by":"crossref","first-page":"349526","DOI":"10.1155\/2013\/349526","article-title":"Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients","volume":"2013","author":"Wlodek","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1111\/ajt.14382_bib73","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1111\/ajt.13358","article-title":"Primary prevention of skin dysplasia in renal transplant recipients with photodynamic therapy: A randomized controlled trial","volume":"15","author":"Togsverd-Bo","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib74","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14382_bib75","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archderm.142.6.729","article-title":"Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial","volume":"142","author":"Morton","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1111\/ajt.14382_bib76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jaad.2010.11.063","article-title":"Skin cancer in solid organ transplant recipients: Advances in therapy and management: Part II. Management of skin cancer in solid organ transplant recipients","volume":"65","author":"Zwald","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib77","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0360-3016(01)01656-X","article-title":"Radiotherapy for epithelial skin cancer","volume":"51","author":"Locke","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/ajt.14382_bib78","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.ejca.2010.02.046","article-title":"Cutaneous squamous cell carcinoma (SCC) of the head and neck: Risk factors of overall and recurrence-free survival","volume":"46","author":"Kyrgidis","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1111\/ajt.14382_bib79","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.07087.x","article-title":"Reduction of immunosuppression for transplant-associated skin cancer: Expert consensus survey","volume":"154","author":"Otley","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib80","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2013.50.6840","article-title":"Sirolimus reduces cutaneous squamous cell carcinomas in transplantation recipients","volume":"31","author":"Colegio","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajt.14382_bib81","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archderm.141.4.456","article-title":"Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: A 16-year retrospective study","volume":"141","author":"Harwood","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/ajt.14382_bib82","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2230.2007.02532.x","article-title":"Sacroiliitis and polyneuropathy during isotretinoin treatment","volume":"33","author":"Eksioglu","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/ajt.14382_bib83","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1346-8138.1991.tb03100.x","article-title":"Acne fulminans and bilateral seronegative sacroiliitis triggered by isotretinoin","volume":"18","author":"Elias","year":"1991","journal-title":"J Dermatol"},{"key":"10.1111\/ajt.14382_bib84","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3899\/jrheum.110703","article-title":"Inflammatory back pain in patients treated with isotretinoin","volume":"38","author":"Pehlivan","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1111\/ajt.14382_bib85","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1440-0960.2002.00613.x","article-title":"Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients","volume":"43","author":"George","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1111\/ajt.14382_bib86","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1399-0012.2010.01348.x","article-title":"Capecitabine for skin cancer prevention in solid organ transplant recipients","volume":"25","author":"Jirakulaporn","year":"2011","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.14382_bib87","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/dsu.12049","article-title":"Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients","volume":"39","author":"Endrizzi","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1111\/ajt.14382_bib88","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/02841860802660502","article-title":"Fatal drug-drug interaction of brivudine and capecitabine","volume":"48","author":"Ratz Bravo","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1111\/ajt.14382_bib89","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14382_bib90","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.14662","article-title":"A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients","volume":"175","author":"Chen","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib91","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women\u2019s Hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajt.14382_bib92","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/ajt.14382_bib93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: Meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1111\/ajt.14382_bib94","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejso.2014.10.055","article-title":"Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma","volume":"41","author":"Allen","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1111\/ajt.14382_bib95","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.medici.2016.09.002","article-title":"Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: Analysis of recurrence-free survival","volume":"52","author":"Samsanavicius","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"10.1111\/ajt.14382_bib96","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/bjd.13508","article-title":"Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma","volume":"172","author":"Krediet","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib97","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1477-7819-9-80","article-title":"Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: Clinical experience and review of literature","volume":"9","author":"Kwon","year":"2011","journal-title":"World J Surg Oncol"},{"key":"10.1111\/ajt.14382_bib98","doi-asserted-by":"crossref","first-page":"267474","DOI":"10.1155\/2013\/267474","article-title":"Sentinel lymph node biopsy in nonmelanoma skin cancer patients","volume":"2013","author":"Matthey-Gie","year":"2013","journal-title":"J Skin Cancer"},{"key":"10.1111\/ajt.14382_bib99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2016.08.051","article-title":"The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management","volume":"76","author":"Ruiz","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib100","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.7314\/APJCP.2014.15.22.9813","article-title":"Evidence based analysis of Cisplatin for treating patients with cutaneous squamous cell carcinoma","volume":"15","author":"Shao","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1111\/ajt.14382_bib101","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1002\/1097-0142(19910415)67:8<2030::AID-CNCR2820670803>3.0.CO;2-K","article-title":"Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin","volume":"67","author":"Khansur","year":"1991","journal-title":"Cancer"},{"key":"10.1111\/ajt.14382_bib102","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s10354-013-0213-5","article-title":"Cetuximab for treatment of advanced squamous cell carcinoma in solid organ transplant recipients","volume":"163","author":"Boyd","year":"2013","journal-title":"Wien Med Wochenschr"},{"key":"10.1111\/ajt.14382_bib103","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/09546634.2012.751481","article-title":"Efficacy of cetuximab in the treatment of squamous cell carcinoma","volume":"25","author":"Preneau","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/ajt.14382_bib104","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.healun.2007.09.019","article-title":"Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab","volume":"26","author":"Leard","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/ajt.14382_bib105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cup.12728","article-title":"PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis","volume":"43","author":"Slater","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1111\/ajt.14382_bib106","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40425-016-0176-3","article-title":"Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810","volume":"4","author":"Falchook","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1111\/ajt.14382_bib107","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMc1509268","article-title":"Tumor regression and allograft rejection after administration of anti-PD-1","volume":"374","author":"Lipson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14382_bib108","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2013.49.2314","article-title":"Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma","volume":"32","author":"Lipson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajt.14382_bib109","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000455014","article-title":"Adverse renal effects of immune checkpoint inhibitors: A narrative review","volume":"45","author":"Wanchoo","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1111\/ajt.14382_bib110","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/bjc.2016.358","article-title":"Acute interstitial nephritis related to immune checkpoint inhibitors","volume":"115","author":"Belliere","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1111\/ajt.14382_bib111","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/ckj\/sfw024","article-title":"Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma","volume":"9","author":"Murakami","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1111\/ajt.14382_bib112","first-page":"177","article-title":"Skin cancer in Caucasian renal allograft recipients living in a subtropical climate","volume":"87","author":"Hardie","year":"1980","journal-title":"Surgery"},{"key":"10.1111\/ajt.14382_bib113","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2133.2006.07154.x","article-title":"Skin lesions in adult liver transplant recipients: A study of 100 consecutive patients","volume":"154","author":"Perera","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib114","first-page":"1172","article-title":"Non-lymphoid cancer after liver transplantation","volume":"44","author":"Frezza","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/ajt.14382_bib115","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1237::AID-CNCR25>3.0.CO;2-5","article-title":"Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors","volume":"83","author":"Kelly","year":"1998","journal-title":"Cancer"},{"issue":"1 Pt 2","key":"10.1111\/ajt.14382_bib116","first-page":"1397","article-title":"De novo malignancy following liver transplantation: A single-center study","volume":"25","author":"Levy","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.14382_bib117","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1172\/JCI57700","article-title":"Mommy - where do tumors come from?","volume":"121","author":"Epstein","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1111\/ajt.14382_bib118","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-4632.2010.04370.x","article-title":"Basal cell carcinoma in a series of renal transplant recipients: Epidemiology and clinicopathologic features","volume":"49","author":"Mertz","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1111\/ajt.14382_bib119","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1200\/JCO.2005.06.237","article-title":"Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: A report from the childhood cancer survivor study","volume":"23","author":"Perkins","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajt.14382_bib120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/EDE.0b013e3181567ebe","article-title":"Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure","volume":"18","author":"Karagas","year":"2007","journal-title":"Epidemiology"},{"key":"10.1111\/ajt.14382_bib121","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/djs298","article-title":"Radiation-related risk of basal cell carcinoma: A report from the Childhood Cancer Survivor Study","volume":"104","author":"Watt","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/ajt.14382_bib122","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/archderm.136.8.1007","article-title":"Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group","volume":"136","author":"Lichter","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/ajt.14382_bib123","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamadermatol.2014.1894","article-title":"Vismodegib for locally advanced basal cell carcinoma in a heart transplant patient","volume":"151","author":"Cusack","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1111\/ajt.14382_bib124","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0002-9343(79)90731-9","article-title":"Kaposi\u2019s sarcoma in recipients of renal transplants","volume":"67","author":"Harwood","year":"1979","journal-title":"Am J Med"},{"key":"10.1111\/ajt.14382_bib125","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1016\/S0041-1345(01)02577-5","article-title":"Kaposi sarcoma: An analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry","volume":"33","author":"Woodle","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.14382_bib126","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ccr.2006.05.026","article-title":"The TSC2\/mTOR pathway drives endothelial cell transformation induced by the Kaposi\u2019s sarcoma-associated herpesvirus G protein-coupled receptor","volume":"10","author":"Sodhi","year":"2006","journal-title":"Cancer Cell"},{"issue":"Suppl 1","key":"10.1111\/ajt.14382_bib127","doi-asserted-by":"crossref","first-page":"i17","DOI":"10.1093\/ndt\/gfm089","article-title":"Kaposi\u2019s sarcoma in renal transplant recipients\u2013the impact of proliferation signal inhibitors","volume":"22","author":"Campistol","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/ajt.14382_bib128","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/01.TP.0000115344.18025.0B","article-title":"Conversion to sirolimus: A successful treatment for posttransplantation Kaposi\u2019s sarcoma","volume":"77","author":"Campistol","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib129","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1128\/JCM.39.2.506-508.2001","article-title":"Kaposi\u2019s sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients","volume":"39","author":"Cattani","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1111\/ajt.14382_bib130","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/00007890-200005150-00008","article-title":"Outcome of kidney transplant recipients with previous human herpesvirus-8 infection","volume":"69","author":"Frances","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib131","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1128\/JCM.40.6.2217-2219.2002","article-title":"Kaposi\u2019s sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients","volume":"40","author":"Emond","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1111\/ajt.14382_bib132","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1034\/j.1399-3046.2002.02006.x","article-title":"Human herpesvirus type 8 infections among solid organ transplant recipients","volume":"6","author":"Allen","year":"2002","journal-title":"Pediatr Transplant"},{"key":"10.1111\/ajt.14382_bib133","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM199811053391903","article-title":"Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients","volume":"339","author":"Regamey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14382_bib134","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2230.2011.04278.x","article-title":"Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: A clinicopathological observation","volume":"37","author":"Prinz Vavricka","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/ajt.14382_bib135","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju382","article-title":"Risk of merkel cell carcinoma after solid organ transplantation","volume":"107","author":"Clarke","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/ajt.14382_bib136","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/00007890-199912150-00015","article-title":"Merkel\u2019s cell carcinoma in organ recipients: Report of 41 cases","volume":"68","author":"Penn","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib137","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jaad.2014.05.054","article-title":"Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation","volume":"71","author":"Arron","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib138","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"10.1111\/ajt.14382_bib139","doi-asserted-by":"crossref","first-page":"874","DOI":"10.6004\/jnccn.2010.0064","article-title":"New virus associated with Merkel cell carcinoma development","volume":"8","author":"Rollison","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1111\/ajt.14382_bib140","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2967\/jnumed.112.116814","article-title":"18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: A 15-year institutional experience","volume":"54","author":"Siva","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1111\/ajt.14382_bib141","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2013.11.031","article-title":"Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel cell carcinoma","volume":"70","author":"Iyer","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib142","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaad.2010.02.056","article-title":"Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system","volume":"63","author":"Lemos","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib143","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1245\/s10434-015-4421-7","article-title":"Negative sentinel lymph node biopsy in merkel cell carcinoma is associated with a low risk of same-nodal-basin recurrences","volume":"22","author":"Grotz","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/ajt.14382_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.22765","article-title":"Merkel cell carcinoma: Critical review with guidelines for multidisciplinary management","volume":"110","author":"Bichakjian","year":"2007","journal-title":"Cancer"},{"key":"10.1111\/ajt.14382_bib145","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/DAD.0b013e3182918f36","article-title":"Localized post-radiation Kaposi sarcoma in a renal transplant immunosuppressed patient","volume":"36","author":"Cota","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/ajt.14382_bib146","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/00007890-199560120-00020","article-title":"Sarcomas in organ allograft recipients","volume":"60","author":"Penn","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib147","first-page":"5511","article-title":"Early and severe radiation toxicity associated with concurrent sirolimus in an organ transplant recipient with head and neck cutaneous squamous cell carcinoma: A case report","volume":"35","author":"Manyam","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1111\/ajt.14382_bib148","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/cam4.815","article-title":"Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma","volume":"5","author":"Iyer","year":"2016","journal-title":"Cancer Med"},{"key":"10.1111\/ajt.14382_bib149","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14382_bib150","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: A multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1111\/ajt.14382_bib151","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2326-6066.CIR-13-0034","article-title":"PD-L1 expression in the Merkel cell carcinoma microenvironment: Association with inflammation, Merkel cell polyomavirus and overall survival","volume":"1","author":"Lipson","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1111\/ajt.14382_bib152","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1158\/0008-5472.CAN-10-2128","article-title":"Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients","volume":"70","author":"Paulson","year":"2010","journal-title":"Cancer Res"},{"key":"10.1111\/ajt.14382_bib153","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1200\/JCO.2010.31.1704","article-title":"High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome","volume":"29","author":"Touze","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajt.14382_bib154","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.2005.07094.x","article-title":"Melanomas in renal transplant recipients","volume":"154","author":"Le Mire","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib155","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/ajt.14382_bib156","doi-asserted-by":"crossref","first-page":"404615","DOI":"10.1155\/2012\/404615","article-title":"Melanoma in organ transplant recipients: Incidence, outcomes and management considerations","volume":"2012","author":"Ali","year":"2012","journal-title":"J Skin Cancer"},{"key":"10.1111\/ajt.14382_bib157","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindelof","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib158","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States","volume":"153","author":"Garrett","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1111\/ajt.14382_bib159","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2016.02.1155","article-title":"Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013","volume":"75","author":"Garrett","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib160","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/jid.2015.312","article-title":"Melanoma risk and survival among organ transplant recipients","volume":"135","author":"Robbins","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ajt.14382_bib161","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2015.03.045","article-title":"Cutaneous malignant melanoma in the Swedish organ transplantation cohort: A study of clinicopathological characteristics and mortality","volume":"73","author":"Krynitz","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib162","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archdermatol.2011.159","article-title":"Malignant melanoma in solid transplant recipients: Collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis","volume":"147","author":"Brewer","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/ajt.14382_bib163","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/j.1600-6143.2008.02326.x","article-title":"Melanoma in organ transplant recipients: Clinicopathological features and outcome in 100 cases","volume":"8","author":"Matin","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib164","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/DSS.0000000000000602","article-title":"Melanoma outcomes in transplant recipients with pretransplant melanoma","volume":"42","author":"Arron","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1111\/ajt.14382_bib165","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1600-6143.2008.02510.x","article-title":"melanoma working group of the international transplant skin cancer C, skin care in organ transplant patients E. Prognosis of pretransplant melanoma","volume":"9","author":"Colegio","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib166","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaad.2008.05.015","article-title":"Outcomes of melanoma in recipients of solid organ transplant","volume":"59","author":"Dapprich","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib167","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ajt.13593","volume":"16","author":"Zwald","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib168","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00007890-200211270-00012","article-title":"Risk for tumor and other disease transmission by transplantation: A population-based study of unrecognized malignancies and other diseases in organ donors","volume":"74","author":"Birkeland","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib169","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00007890-198011000-00003","article-title":"Inadvertent transplantation of a melanoma","volume":"30","author":"Fairman","year":"1980","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14382_bib170","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1399-0012.2006.00514.x","article-title":"The transmission of donor-derived malignant melanoma to a renal allograft recipient","volume":"20","author":"Milton","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.14382_bib171","first-page":"7","article-title":"Transmission of cancer from organ donors","volume":"2","author":"Penn","year":"1997","journal-title":"Ann Transplant"},{"key":"10.1111\/ajt.14382_bib172","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(10)70024-3","article-title":"Transmission of donor melanoma by organ transplantation","volume":"11","author":"Strauss","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1111\/ajt.14382_bib173","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1111\/ajt.12430","article-title":"Donor cancer transmission in kidney transplantation: A systematic review","volume":"13","author":"Xiao","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib174","first-page":"228","article-title":"Melanoma: Molecular pathogenesis and therapeutic management","volume":"6","author":"Liu","year":"2014","journal-title":"Mol Cell Pharmacol"},{"key":"10.1111\/ajt.14382_bib175","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"10.1111\/ajt.14382_bib176","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2340\/00015555-2148","article-title":"Increased risk of melanoma in organ transplant recipients: Systematic review and meta-analysis of cohort studies","volume":"95","author":"Green","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/ajt.14382_bib177","first-page":"56","article-title":"novo malignances in pediatric organ transplant recipients","volume":"2","author":"De","year":"1998","journal-title":"Pediatr Transplant"},{"key":"10.1111\/ajt.14382_bib178","doi-asserted-by":"crossref","first-page":"330e","DOI":"10.1097\/PRS.0000000000002367","article-title":"Malignant melanoma: Beyond the basics","volume":"138","author":"Pavri","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/ajt.14382_bib179","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1200\/EDBK_159087","article-title":"Surgical management and adjuvant therapy for high-risk and metastatic melanoma","volume":"35","author":"van Akkooi","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1111\/ajt.14382_bib180","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjd.13675","article-title":"No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: Critical appraisal of the multicenter selective lymphadenectomy trial-I final report","volume":"172","author":"Sladden","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1111\/ajt.14382_bib181","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jso.20084","article-title":"Lessons learned from the sunbelt melanoma trial","volume":"86","author":"McMasters","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1111\/ajt.14382_bib182","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1600-6143.2010.03078.x","article-title":"Melanoma in solid organ transplant recipients","volume":"10","author":"Zwald","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib183","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jdcr.2015.09.020","article-title":"Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature","volume":"1","author":"Garrett","year":"2015","journal-title":"JAAD Case Rep"},{"key":"10.1111\/ajt.14382_bib184","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/annonc\/mdw130","article-title":"Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma","volume":"27","author":"Spain","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1111\/ajt.14382_bib185","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/ajt.13711","article-title":"Checkpoint inhibitors in kidney transplant recipients and the potential risk of rejection","volume":"16","author":"Alhamad","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14382_bib186","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/CJI.0000000000000077","article-title":"Administration of ipilimumab to a liver transplant recipient with unresectable metastatic melanoma","volume":"38","author":"Ranganath","year":"2015","journal-title":"J Immunother"},{"key":"10.1111\/ajt.14382_bib187","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejca.2016.07.026","article-title":"Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient","volume":"67","author":"Herz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1111\/ajt.14382_bib188","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1067\/mjd.2003.97","article-title":"High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients","volume":"48","author":"Harwood","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib189","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/ijc.24931","article-title":"Skin cancers associated with HIV infection and solid-organ transplantation among elderly adults","volume":"126","author":"Lanoy","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1111\/ajt.14382_bib190","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1523-1747.2001.01233.x","article-title":"An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients","volume":"116","author":"Harwood","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ajt.14382_bib191","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5858\/arpa.2014-0495-RS","article-title":"Atypical fibroxanthoma","volume":"140","author":"Lopez","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1111\/ajt.14382_bib192","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1524-4725.2011.02180.x","article-title":"Clinical spectrum of atypical fibroxanthoma and undifferentiated pleomorphic sarcoma in solid organ transplant recipients: A collective experience","volume":"38","author":"McCoppin","year":"2012","journal-title":"Dermatol Surg"},{"issue":"12 Pt 2","key":"10.1111\/ajt.14382_bib193","first-page":"1561","article-title":"Localized cutaneous metastases from an atypical fibroxanthoma","volume":"30","author":"Giuffrida","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1111\/ajt.14382_bib194","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaad.2010.11.062","article-title":"Skin cancer in solid organ transplant recipients: Advances in therapy and management: Part I. Epidemiology of skin cancer in solid organ transplant recipients","volume":"65","author":"Zwald","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ajt.14382_bib195","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaad.2015.03.021","article-title":"Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC","volume":"72","author":"Sekulic","year":"2015","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14382","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.14382","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.14382","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522251570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522251570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.14382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:18:40Z","timestamp":1761628720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522251570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":195,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1600613522251570"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14382","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin Cancers in Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}